BIOSYNEX (ALBIO.PA) Stock Cash Flow
EPA:ALBIO - Euronext Paris - Matif - FR0011005933 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -37.16M | -35.61M | 15.60M | 106.70M | 31.40M | |||
| Depreciation Amortization | 9.87M | 13.46M | 26.90M | 2.00M | 7.20M | |||
| Income Taxes - Deferred | -1.46M | -2.00M | -300.00K | 500.00K | 200.00K | |||
| Change In Working Capital | 17.82M | 14.51M | -37.30M | 600.00K | -7.20M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | -200.00K | |||
| Other non cash items | 4.00K | -17.00K | 0.00 | 0.00 | 0.00 | |||
| OPERATING CASH FLOW | -10.92M | -9.65M | 4.90M | 109.80M | 31.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -9.64M | -39.54M | -30.10M | -19.00M | -9.10M | |||
| Other Investing Activity | 838.00K | -15.27M | -9.00M | -9.90M | 1.20M | |||
| INVESTING CASH FLOW | -8.80M | -54.81M | -39.10M | -29.00M | -7.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -12.04M | 7.58M | 12.10M | 16.80M | 6.00M | |||
| Stock Issued/Repurchased | -725.00K | -3.22M | -1.70M | -700.00K | 4.40M | |||
| Other Financing Activity | 96.00K | 808.00K | -21.20M | -1.80M | 200.00K | |||
| FINANCING CASH FLOW | -12.67M | 5.17M | -10.80M | 14.40M | 10.60M | |||
| CHANGE IN CASH | -32.40M | -59.30M | -45.00M | 95.20M | 34.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.92M | -9.65M | 4.90M | 109.80M | 31.60M | |||
| Capital Expenditure | -9.64M | -39.54M | -30.10M | -19.00M | -9.10M | |||
| FREE CASH FLOW | -20.56M | -49.20M | -25.20M | 90.80M | 22.50M | |||
All data in EUR